Publication Date:  August 16, 2018

Update Date: August 16, 2018

 

Philips is currently monitoring updates related to the recent advisory by Intel regarding three recently discovered CPU-related vulnerabilities, currently designated “L1 Terminal Fault” or L1TF. Intel has disclosed that the L1 Terminal Fault vulnerabilities affect the company’s processors manufactured from 2009 to 2018. The three L1 terminal fault vulnerabilities are designated as high risk, and if exploited may lead to unauthorized disclosure of information within an L1 data cache.

 

Intel further reports it has developed firmware and software updates to minimize potential exploitation of these issues. (See Intel Advisory: https://www.intel.com/content/www/us/en/security-center/advisory/intel-sa-00161.html)

 

As part of Philips’ product security policy and protocols, the company’s global product security team is actively evaluating potential impacts on Philips solutions. At this time, Philips has not received reports of these vulnerabilities affecting clinical use of company products.

 

Philips advises customers with product concerns relating to these vulnerabilities should send an email to productsecurity@philips.com. Further information regarding Philips’ recommendations regarding this event may be found at the Philips product security web site: https://www.philips.com/productsecurity

 

Customers with questions regarding their specific products are advised to contact their local Philips service support team or their regional service support. Philips contact information is available at the following web page:

https://www.usa.philips.com/healthcare/solutions/customer-service-solutions